Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Djamila Talbi
Zoltan Gal

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Sensors (Basel, Switzerland)|December 11, 2025
Higher-Order Markov Model-Based Analysis of Reinforcement Learning in 6G Mobile Retrial Queueing SystemsDjamila Talbi, Zoltan Gal
Sensors (Basel, Switzerland)|June 27, 2025
Integrating Reinforcement Learning into M/M/1/K Retry Queueing Models for 6G ApplicationsDjamila Talbi, Zoltan Gal
Acta Crystallographica. Section E, Crystallographic Communications|June 1, 2018
Studying weak inter-actions in crystals at high pressures: when hardware mattersBoris A Zakharov, Zoltan Gal, Dyanne Cruickshank, et al.
International Journal of Radiation Oncology, Biology, Physics|August 10, 2015
Radiosensitivity of Patient-Derived Glioma Stem Cell 3-Dimensional Cultures to Photon, Proton, and Carbon IrradiationSara Chiblak, Zili Tang, Benito Campos, et al.
Cancer Biology & Therapy|January 23, 2014
Antiproliferative efficacies but minor drug transporter inducing effects of paclitaxel, cisplatin, or 5-fluorouracil in a murine xenograft model for head and neck squamous cell carcinomaDirk Theile, Zoltan Gal, Rolf Warta, et al.
International Journal of Cancer|August 29, 2019
Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulationJan-Philipp Mallm, Paul Windisch, Alva Biran, et al.
Anticancer Research|April 13, 2016
Combined Treatment of ATRA with Epigenetic Drugs Increases Aggressiveness of Glioma XenograftsThomas Schmoch, Zoltan Gal, Andreas Mock, et al.
The Journal of Pathology|April 24, 2014
Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastomaBenito Campos, Zoltan Gal, Aline Baader, et al.
Cancer Research|January 8, 2013
Specific elimination of CD133+ tumor cells with targeted oncolytic measles virusPatricia Bach, Tobias Abel, Christopher Hoffmann, et al.
Acta Neuropathologica|March 24, 2017
Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimensCarmen Rapp, Rolf Warta, Slava Stamova, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Sensors (Basel, Switzerland)|December 11, 2025
Higher-Order Markov Model-Based Analysis of Reinforcement Learning in 6G Mobile Retrial Queueing SystemsDjamila Talbi, Zoltan Gal
Sensors (Basel, Switzerland)|June 27, 2025
Integrating Reinforcement Learning into M/M/1/K Retry Queueing Models for 6G ApplicationsDjamila Talbi, Zoltan Gal
Acta Crystallographica. Section E, Crystallographic Communications|June 1, 2018
Studying weak inter-actions in crystals at high pressures: when hardware mattersBoris A Zakharov, Zoltan Gal, Dyanne Cruickshank, et al.
International Journal of Radiation Oncology, Biology, Physics|August 10, 2015
Radiosensitivity of Patient-Derived Glioma Stem Cell 3-Dimensional Cultures to Photon, Proton, and Carbon IrradiationSara Chiblak, Zili Tang, Benito Campos, et al.
Cancer Biology & Therapy|January 23, 2014
Antiproliferative efficacies but minor drug transporter inducing effects of paclitaxel, cisplatin, or 5-fluorouracil in a murine xenograft model for head and neck squamous cell carcinomaDirk Theile, Zoltan Gal, Rolf Warta, et al.
International Journal of Cancer|August 29, 2019
Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulationJan-Philipp Mallm, Paul Windisch, Alva Biran, et al.
Anticancer Research|April 13, 2016
Combined Treatment of ATRA with Epigenetic Drugs Increases Aggressiveness of Glioma XenograftsThomas Schmoch, Zoltan Gal, Andreas Mock, et al.
The Journal of Pathology|April 24, 2014
Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastomaBenito Campos, Zoltan Gal, Aline Baader, et al.
Cancer Research|January 8, 2013
Specific elimination of CD133+ tumor cells with targeted oncolytic measles virusPatricia Bach, Tobias Abel, Christopher Hoffmann, et al.
Acta Neuropathologica|March 24, 2017
Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimensCarmen Rapp, Rolf Warta, Slava Stamova, et al.
Pageof 1